4.84
price up icon14.15%   0.60
after-market Handel nachbörslich: 4.81 -0.03 -0.62%
loading

Urogen Pharma Ltd Aktie (URGN) Neueste Nachrichten

pulisher
12:00 PM

Deadline Approaching: UroGen Pharma Ltd. (URGN) Investors Who Lost Money Urged To Contact Law Offices of Howard G. Smith - Business Wire

12:00 PM
pulisher
11:26 AM

UroGen Presents uTRACT Registry at ASCO 2025 Annual Meeting Desi - GuruFocus

11:26 AM
pulisher
11:00 AM

UroGen Presents uTRACT Registry at ASCO 2025 Annual Meeting Designed to Study Real-World Use of JELMYTO in Low-Grade Upper Tract Urothelial Cancer - Business Wire

11:00 AM
pulisher
10:55 AM

UroGen presents promising bladder cancer study results - Investing.com Australia

10:55 AM
pulisher
10:34 AM

UroGen presents promising bladder cancer study results By Investing.com - Investing.com Canada

10:34 AM
pulisher
10:00 AM

UroGen Announces Data at ASCO 2025 Annual Meeting on UGN-102, an Investigational Treatment for Recurrent Low-Grade Intermediate-Risk Non-Muscle Invasive Bladder Cancer (LG-IR-NMIBC) - Business Wire

10:00 AM
pulisher
09:53 AM

URGN Investors Have Opportunity to Lead UroGen Pharma Ltd. Securities Fraud Lawsuit with the Schall Law Firm - PR Newswire

09:53 AM
pulisher
09:25 AM

URGN INVESTOR NOTICE: UroGen Pharma Ltd. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit – Company AnnouncementFT.com - Financial Times

09:25 AM
pulisher
Jun 01, 2025

Lost Money on UroGen Pharma Ltd. (URGN)? Join Class Action Before July 28, 2025Contact Levi & Korsinsky - ACCESS Newswire

Jun 01, 2025
pulisher
Jun 01, 2025

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of UroGen Pharma Ltd.URGN - PR Newswire

Jun 01, 2025
pulisher
Jun 01, 2025

ONGOING DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of UroGen - StreetInsider

Jun 01, 2025
pulisher
Jun 01, 2025

Securities Lawsuit Alert: UroGen Pharma Ltd. (URGN) InvestorsContact Levi & Korsinsky Before July 28, 2025 - ACCESS Newswire

Jun 01, 2025
pulisher
May 31, 2025

Class Action Lawsuit Filed: UroGen Pharma Ltd. (URGN)Join by July 28, 2025Contact Levi & Korsinsky - ACCESS Newswire

May 31, 2025
pulisher
May 31, 2025

URGN CLASS ACTION NOTICE: UroGen Pharma Ltd. has been Sued - GlobeNewswire

May 31, 2025
pulisher
May 30, 2025

Levi & Korsinsky Investigates UroGen Pharma Ltd. (URGN) Over Possible Securities Fraud - ACCESS Newswire

May 30, 2025
pulisher
May 30, 2025

Pharma Co. Hid Cancer Study Method Problems, Investor Claims - Law360

May 30, 2025
pulisher
May 30, 2025

URGN ALERT: Kirby McInerney LLP Announces the Filing of a Securities Class Action on Behalf of UroGen Pharma Ltd. Investors - Business Wire

May 30, 2025
pulisher
May 30, 2025

URGN INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC - GlobeNewswire

May 30, 2025
pulisher
May 30, 2025

URGN Investor Notice: Robbins LLP Reminds Stockholders of the Class Action Lawsuit Against ... - Eagle-Tribune

May 30, 2025
pulisher
May 30, 2025

Investigation Opened on Behalf of UroGen Pharma Ltd. (URGN) ShareholdersContact Levi & Korsinsky - ACCESS Newswire

May 30, 2025
pulisher
May 30, 2025

Ongoing Securities Investigation into UroGen Pharma Ltd. (URGN)Contact Levi & Korsinsky - ACCESS Newswire

May 30, 2025
pulisher
May 30, 2025

URGN FRAUD ALERT: UroGen Pharma Ltd. Investors are Alerted to Contact BFA Law about the Pending Securities Fraud Class Action - Newsfile

May 30, 2025
pulisher
May 30, 2025

URGN STOCKHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that UroGen Pharma Ltd. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit! - ACCESS Newswire

May 30, 2025
pulisher
May 30, 2025

UroGen Pharma Ltd. (URGN) Faces Securities Class Action - GlobeNewswire

May 30, 2025
pulisher
May 30, 2025

URGN BREAKING NEWS: UroGen Pharma Ltd. Stock Plummets 45% Triggering Shareholder Class Action – Contact BFA Law if You Lost Money (NASDAQ:URGN) - Business Wire

May 30, 2025
pulisher
May 30, 2025

UroGen Investor Sues After Cancer Therapy Setback, 45% Selloff - Bloomberg Law News

May 30, 2025
pulisher
May 30, 2025

Gainey McKenna & Egleston Announces A Class Action Lawsuit Has Been Filed Against UroGen Pharma Ltd. (URGN) - GlobeNewswire Inc.

May 30, 2025
pulisher
May 30, 2025

INVESTOR ALERT: Class Action Lawsuit Filed on Behalf of - GlobeNewswire

May 30, 2025
pulisher
May 30, 2025

URGN Investors Have the Opportunity to Lead the UroGen Pharma Securities Fraud Lawsuit with Faruqi & Faruqi, LLP - PR Newswire

May 30, 2025
pulisher
May 30, 2025

UroGen Pharma Ltd. (NASDAQ:URGN) Given Consensus Recommendation of “Moderate Buy” by Brokerages - Defense World

May 30, 2025
pulisher
May 29, 2025

URGN Stockholder Alert: Robbins LLP Informs Investors of the UroGen Pharma Ltd. Class Action Lawsuit - Morningstar

May 29, 2025
pulisher
May 29, 2025

UroGen Pharma Ltd. Investors: Please contact the Portnoy - GlobeNewswire

May 29, 2025
pulisher
May 29, 2025

URGN INVESTOR ALERT: UroGen Pharma Ltd. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit – Company AnnouncementFT.com - Financial Times

May 29, 2025
pulisher
May 29, 2025

DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of UroGen - Business Wire

May 29, 2025
pulisher
May 29, 2025

Law Offices of Howard G. Smith Encourages UroGen Pharma Ltd. (URGN) Investors To Inquire About Securities Fraud Class Action - Business Wire

May 29, 2025
pulisher
May 29, 2025

UroGen Pharma Ltd. (URGN) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Shareholders to Contact the Firm to Learn More About the Investigation - ACCESS Newswire

May 29, 2025
pulisher
May 29, 2025

Did You Suffer Losses in UroGen Pharma Ltd. (URGN)? Contact Levi & Korsinsky About Securities Fraud Claims - ACCESS Newswire

May 29, 2025
pulisher
May 29, 2025

UroGen Pharma Ltd. (URGN) Shares Crash Again Amid FDA's ODAC Vote Against UGN-102, Company Facing Investor ScrutinyHagens Berman - PR Newswire

May 29, 2025
pulisher
May 28, 2025

Did UroGen Pharma Ltd. (URGN) Mislead Investors? Levi & Korsinsky Investigates - ACCESS Newswire

May 28, 2025
pulisher
May 28, 2025

Oppenheimer maintains Outperform on UroGen Pharma stock By Investing.com - Investing.com India

May 28, 2025
pulisher
May 27, 2025

Lost Money on UroGen Pharma Ltd. (URGN)? Contact Levi & Korsinsky to Protect Your Rights - ACCESS Newswire

May 27, 2025
pulisher
May 27, 2025

UroGen Pharma to Present at TD Cowen: 6th Annual Oncology Innovation Summit: Insights for ASCO & EHA - New Castle News

May 27, 2025
pulisher
May 27, 2025

UroGen Pharma Ltd. (URGN) Shares Crash Again Amid FDA’s - GlobeNewswire

May 27, 2025
pulisher
May 27, 2025

UroGen Pharma Ltd. (NASDAQ:URGN) Stock Position Decreased by Millennium Management LLC - Defense World

May 27, 2025
pulisher
May 26, 2025

Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against UroGen Pharma Ltd. (URGN) and Encourages Investors to Learn More About the Investigation - ACCESS Newswire

May 26, 2025
pulisher
May 26, 2025

Janus Henderson Group PLC Acquires New Stake in UroGen Pharma Ltd. (NASDAQ:URGN) - Defense World

May 26, 2025
pulisher
May 26, 2025

Lazard Asset Management LLC Acquires New Holdings in UroGen Pharma Ltd. (NASDAQ:URGN) - Defense World

May 26, 2025
pulisher
May 26, 2025

Q2 EPS Estimates for UroGen Pharma Raised by HC Wainwright - Defense World

May 26, 2025
pulisher
May 25, 2025

UroGen Pharma Stock Receives Downgrade As Analyst Cites FDA Panel Setback For Key Bladder Cancer Drug - Benzinga

May 25, 2025
pulisher
May 25, 2025

Guggenheim Has Lowered Expectations for UroGen Pharma (NASDAQ:URGN) Stock Price - Defense World

May 25, 2025
pulisher
May 25, 2025

The Goldman Sachs Group Cuts UroGen Pharma (NASDAQ:URGN) Price Target to $3.00 - Defense World

May 25, 2025
pulisher
May 24, 2025

Ongoing Investigation: UroGen Pharma Ltd. (URGN) May Have Misled ShareholdersLevi & Korsinsky Investigates - ACCESS Newswire

May 24, 2025
pulisher
May 24, 2025

Northern Trust Corp Purchases 23,345 Shares of UroGen Pharma Ltd. (NASDAQ:URGN) - Defense World

May 24, 2025
pulisher
May 24, 2025

Kaplan Fox Reminds Investors of UroGen Pharma Ltd. (URGN) to an Investigation of Potential Securities Law Violations - FinancialContent

May 24, 2025
pulisher
May 23, 2025

Guggenheim's Michael Schmidt Lowers Price Target for UroGen Pharma (URGN) | URGN Stock News - GuruFocus

May 23, 2025
pulisher
May 23, 2025

Kaplan Fox is Investigating Potential Securities Law Violations against UroGen Pharma Ltd. (URGN) - FinancialContent

May 23, 2025
pulisher
May 23, 2025

UroGen Pharma (URGN) Price Target Cut by Guggenheim | URGN Stock News - GuruFocus

May 23, 2025
pulisher
May 23, 2025

URGN ACTIVE INVESTIGATION: Lost Money on UroGen Pharma Ltd.? Contact Levi & Korsinsky Now - ACCESS Newswire

May 23, 2025
pulisher
May 23, 2025

UroGen crashes as FDA AdCom rebukes bladder cancer drug - MSN

May 23, 2025
pulisher
May 22, 2025

UroGen Pharma Shares Fall After HC Wainwright Downgrade - marketscreener.com

May 22, 2025
pulisher
May 22, 2025

Kaplan Fox Announces an Investigation Into UroGen Pharma Ltd. (URGN) for Potential Securities Law Violations - FinancialContent

May 22, 2025
pulisher
May 22, 2025

UroGen Pharma (URGN) Target Price Slashed by Goldman Sachs | URGN Stock News - GuruFocus

May 22, 2025
pulisher
May 22, 2025

Goldman Sachs cuts UroGen Pharma target to $3 from $16 - Investing.com Australia

May 22, 2025
pulisher
May 22, 2025

UroGen tanks as FDA panel vote goes against UGN-102 - The Pharma Letter

May 22, 2025
pulisher
May 22, 2025

This Guidewire Software Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Thursday - Benzinga

May 22, 2025
pulisher
May 22, 2025

HC Wainwright Downgrades UroGen Pharma to Neutral From Buy - marketscreener.com

May 22, 2025
pulisher
May 22, 2025

UroGen Pharma (URGN) Downgraded by HC Wainwright & Co. | URGN Stock News - GuruFocus

May 22, 2025
$1.15
price up icon 6.48%
$31.19
price up icon 3.48%
$584.61
price up icon 1.98%
$306.09
price up icon 0.50%
$4.5994
price up icon 2.21%
$490.81
price up icon 0.11%
Kapitalisierung:     |  Volumen (24h):